We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

35 hedge funds and large institutions have $125K invested in Ampio Pharmaceuticals Inc. in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

37% more capital invested

Capital invested by funds: $90.8K → $125K (+$33.9K)

6% more funds holding

Funds holding: 33 → 35 (+2)

63% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 8

Holders
35
Holders Change
+2
Holders Change %
+6.06%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
3
Reduced
8
Closed
3
Calls
$71K
Puts
–
Net Calls
+$71K
Net Calls Change
-$118K

Top Buyers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
+$56.9K
2
Renaissance Technologies
Renaissance Technologies
New York
+$4.83K
3
VF
Virtu Financial
New York
+$4.21K
4
TSS
Two Sigma Securities
New York
+$3.9K
5
Goldman Sachs
Goldman Sachs
New York
+$3.63K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$18.7K
2
Millennium Management
Millennium Management
New York
-$6.39K
3
CC
Courier Capital
New York
-$4.6K
4
SG
StoneX Group
New York
-$4.53K
5
Group One Trading
Group One Trading
Illinois
-$1.11K

AMPE Hedge Fund Activity: Q1 2023 in Review

35 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2023, worth a combined $125K — up 37% from $90.8K a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new AMPE positions and 3 closed out — a net gain of 4 holders — while 3 added to existing stakes and 8 trimmed.

The largest buyer was HRT Financial, adding an estimated $56.9K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $18.7K sold.

  • 35 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2023, up from 33 in Q4 2022.
  • Funds reported $125K of Ampio Pharmaceuticals Inc. stock for Q1 2023, up 37% quarter-over-quarter.
  • 7 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2023 and 3 closed out, a net change of +4 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q1 2023 was HRT Financial, an estimated $56.9K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q1 2023 was Susquehanna International Group, an estimated $18.7K sold.

Based on aggregated 13F filings for Q1 2023.